ArticleMolecular therapy : the journal of the American Society of Gene Therapy2009

The pharmacological chaperone N-butyldeoxynojirimycin enhances enzyme replacement therapy in Pompe disease fibroblasts.

Caterina Porto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.